-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the enterprise research app, Guangdong Hengqin Ruilin Zhiyan Pharmaceutical Technology Co., Ltd. was established recently. The legal representative is Liu Fangxiu. The business scope includes medical research and experimental development; information technology consulting services; market research; health consulting services, etc. Enterprise investigation and equity penetration shows that the company is wholly owned by Tiger Pharmaceuticals indirectly.
Share
Listen to the news
According to the enterprise research app, Guangdong Hengqin Ruilin Zhiyan Pharmaceutical Technology Co., Ltd. was established recently. The legal representative is Liu Fangxiu. The business scope includes medical research and experimental development; information technology consulting services; market research; health consulting services, etc. Enterprise investigation and equity penetration shows that the company is wholly owned by Tiger Pharmaceuticals indirectly.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending